Proposed Data Collection Submitted for Public Comment and Recommendations, 38148-38150 [2024-09852]
Download as PDF
38148
Federal Register / Vol. 89, No. 89 / Tuesday, May 7, 2024 / Notices
and annually since 1989. The survey is
conducted under authority of Section
306 of the Public Health Service Act (42
U.S.C. 242k). The National Hospital
Discharge Survey (NHDS) (OMB No.
0920–0212, Exp. Date 01/31/2019),
conducted continuously between 1965
and 2010, was the Nation’s principal
source of data on inpatient utilization of
short-stay, non-institutional, nonFederal hospitals, and was the principal
source of nationally representative
estimates on the characteristics of
inpatients including lengths of stay,
diagnoses, surgical and non-surgical
procedures, and patterns of use of care
in hospitals in various regions of the
country. In 2011, NHDS was granted
approval by OMB to expand its content
and to change its name to the National
Hospital Care Survey (NHCS).
In May 2011, recruitment of sampled
hospitals for the NHCS began. Hospitals
in the NHCS are asked to provide data
on all inpatients from their UB–04
administrative claims, or EHRs.
Hospital-level characteristics and
information about telemedicine usage in
the healthcare setting are collected
through an Annual Hospital Interview.
health care acquired infections and
antimicrobial use.
Beginning in 2013, in addition to
inpatient hospital data, hospitals
participating in NHCS were asked to
provide data on the utilization of health
care services in their ambulatory
settings (e.g., EDs and OPDs). Due to
low response rates and a high level of
missing data, OPD data were not
collected in the last approval period
(2022, 2023 and 2024). Collection of
OPD may resume in future years.
Data collected through NHCS are
essential for evaluating the health status
of the population, for the planning of
programs and policy to improve health
care delivery systems of the Nation, for
studying morbidity trends, and for
research activities in the health field.
Changes to the data collection survey
include the removal of COVID–19
questions from the Annual Hospital
Interview (AHI). The burden hours have
been reduced due to a decrease in the
sample size. The new total annualized
burden is 5,826 hours. There is no cost
to respondents other than their time to
participate.
NHCS will continue to provide the same
national health-care statistics on
hospitals that NHDS provided.
Additionally, NHCS collects more
information at the hospital level (e.g.,
volume of care provided by the
hospital), which allow for analyses on
the effect of hospital characteristics on
the quality of care provided. NHCS data
collected from UB–04 administrative
claims and EHRs include all inpatient
discharges, not just a sample. The
confidential collection of personally
identifiable information (PII) allows
NCHS to link episodes of care provided
to the same patient in the ED and/or
OPD and as an inpatient, as well as link
patients to the National Death Index
(NDI) to measure post-discharge
mortality, and Medicare and Medicaid
data to leverage comorbidities. The
availability of patient identifiers also
makes analysis on hospital readmissions
possible. This comprehensive collection
of data makes future opportunities for
surveillance possible, including
analyzing trends and incidence of
opioid misuse, acute myocardial
infarction, heart failure and stroke, as
well as trends and point prevalence of
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Avg. burden
per response
(in hours)
Total burden
(in hours)
Form name
Hospital DHIM or DHIT .....................
Hospital CEO/CFO ............................
Hospital DHIM or DHIT .....................
123
30
356
1
1
12
1
1
1
123
30
4,272
200
4
1
800
Hospital CEO/CFO ............................
Initial Hospital Intake Questionnaire
Recruitment Survey Presentation ....
Prepare and transmit UB–04 or
State File for Inpatient and Ambulatory (monthly).
Prepare and transmit EHR for Inpatient and Ambulatory (quarterly).
Annual Hospital Interview ................
601
1
1
601
Total ...........................................
...........................................................
........................
........................
........................
5,826
Hospital DHIM or DHIT .....................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[FR Doc. 2024–09855 Filed 5–6–24; 8:45 am]
[60-Day–24–24FA; Docket No. CDC–2024–
0032]
BILLING CODE 4163–18–P
Proposed Data Collection Submitted
for Public Comment and
Recommendations
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Respondents
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
SUMMARY:
VerDate Sep<11>2014
15:55 May 06, 2024
Jkt 262001
PO 00000
Frm 00131
Fmt 4703
Sfmt 4703
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on an information collection
project titled Human-Centered Design
Effort on Bringing Guidelines to the
Digital Age. This information collection
will allow CDC to understand pain
points in developing solutions that help
develop and implement guidelines that
leverage technology to improve patient
care.
CDC must receive written
comments on or before July 8, 2024.
DATES:
You may submit comments,
identified by Docket No. CDC–2024–
0032 by either of the following methods:
ADDRESSES:
E:\FR\FM\07MYN1.SGM
07MYN1
38149
Federal Register / Vol. 89, No. 89 / Tuesday, May 7, 2024 / Notices
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
Background and Brief Description
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Given the increased demand to
improve clinical guideline development
and implementation, a new approach
that began with an initiative on
Adapting Clinical Guidelines for the
Digital Age has been expanded by
Guidelines International Network (GIN)
North America to implement a future
state of guideline development and
implementation that leverages
advancements in technology. To
identify pain points in the process, CDC
plans to engage individuals from
multiple perspectives in guideline
development and implementation in
discussion. CDC requests approval for
an Existing Collection in Use Without
an OMB Control Number for a data
collection titled Human-Centered
Design Effort on Bringing Guidelines to
the Digital Age.
CDC will use semi-structured
interviews to collect data for this study.
The interviews will explore insights
about guideline development and
implementation as well as pain points
in this process. Data will be used to
inform the structure of a humancentered design workshop where
participants use the pain points
identified as starting points for
designing solutions. Burden estimates
include the time for respondents to be
participate in semi-structured
interviews. CDC requests OMB approval
for an estimated 33 annual burden
hours. There is no cost to respondents
other than their time to participate.
Proposed Project
Human-Centered Design Effort on
Bringing Guidelines to the Digital Age—
Existing Collection in Use Without an
OMB Control Number—Office of Public
Health Data, Surveillance, and
Technology (OPHDST), Centers for
Disease Control and Prevention (CDC).
ESTIMATED ANNUALIZED BURDEN HOURS
Form Name
Clinicians ...........................................
EHR Vendors ....................................
Guideline Developers ........................
Clinician Conversation Guide ...........
EHR Vendor Conversation Guide ....
Guideline Developer Conversation
Guide.
Informaticist Conversation Guide .....
Implementer Conversation Guide ....
Insurer Conversation Guide .............
Patient/Patient Advocate Conversation Guide.
Informaticists .....................................
Implementers ....................................
Insurers .............................................
Patient/Patient Advocate ...................
khammond on DSKJM1Z7X2PROD with NOTICES
Total ...........................................
VerDate Sep<11>2014
15:55 May 06, 2024
...........................................................
Jkt 262001
PO 00000
Frm 00132
Fmt 4703
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Type of respondent
Total
burden
(in hours)
5
2
8
1
1
1
1
1
1
5
2
8
4
9
1
4
1
1
1
1
1
1
1
1
4
9
1
4
........................
........................
........................
33
Sfmt 4703
E:\FR\FM\07MYN1.SGM
07MYN1
38150
Federal Register / Vol. 89, No. 89 / Tuesday, May 7, 2024 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–09852 Filed 5–6–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–1355; Docket No. CDC–2024–
0022]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Evaluation of
the Division of Overdose Prevention
Technical Assistance Center. This data
collection allows CDC to collect
information from partner organizations
regarding feedback on their experiences
receiving technical assistance.
DATES: CDC must receive written
comments on or before July 8, 2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0022 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
15:55 May 06, 2024
Jkt 262001
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of the Division of
Overdose Prevention Technical
Assistance Center (OMB Control No.,
0920–1355, Exp. 11/30/202)—
Revision—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is submitting a
Revision request for the currently
PO 00000
Frm 00133
Fmt 4703
Sfmt 4703
approved Evaluating the Overdose Data
to Action TA Hub (OMB Control No.
0920–1355, Exp. Date 11/30/2024) for
three years. CDC requests a three-year
OMB approval to support the evaluation
of technical assistance (TA) provided for
the Overdose Data to Action (OD2A) in
States (S) and OD2A: Limiting Overdose
through Collaborative Actions in
Localities (LOCAL) programs. OD2A–S
and OD2A: LOCAL are cooperative
agreements funded in 2023 to focus on
comprehensive and interdisciplinary
opioid overdose prevention efforts in 49
state health departments, 39 localities,
Puerto Rico, and Washington, DC. Each
program consists of two required
components—a surveillance component
and a prevention component. OD2A
recipients implement a combination of
activities across nine state strategies and
eight local strategies within these
components in order to gain access to
high quality, complete, and timelier
data on opioid prescribing and
overdoses and to use those data to
inform prevention and response efforts
in their jurisdictions.
In the previously approved iteration
of this data collection, the information
collected surrounding OD2A (version
1.0) recipient feedback on their
experiences receiving TA proved
invaluable in the process of improving
TA delivery and overall providing more
useful TA. The feedback provided in the
original data collection instruments was
also used to improve the TA Strategy of
the updated iterations of OD2A
(including OD2A–S and OD2A: LOCAL)
and their recipients. With the
information that was collected in the
previously approved ICR, CDC can more
effectively deliver TA to an almostdoubled recipient group across two
programs instead of one and ensure that
continuous improvement in TA is
occurring. Further information gathering
through the two new instruments
proposed in this ICR (the
Implementation Feedback Form and the
Focus Group script), will even more
acutely enhance TA perspectives and
needs to effectively and responsibly
utilize the DOP TA Center resource.
Training and technical assistance
(TA) is essential to building knowledge
and strengthening the capacity of
recipients to implement and evaluate
OD2A program strategies. CDC will
develop and deploy a TA hub (hereafter
referred to as the DOP TA Center) to
deliver comprehensive technical
assistance and training to support the
successful implementation and
evaluation of surveillance and
prevention activities. The DOP TA
Center is designed to enhance the
efficiency, coordination, and
E:\FR\FM\07MYN1.SGM
07MYN1
Agencies
[Federal Register Volume 89, Number 89 (Tuesday, May 7, 2024)]
[Notices]
[Pages 38148-38150]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09852]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-24-24FA; Docket No. CDC-2024-0032]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on an information collection project titled
Human-Centered Design Effort on Bringing Guidelines to the Digital Age.
This information collection will allow CDC to understand pain points in
developing solutions that help develop and implement guidelines that
leverage technology to improve patient care.
DATES: CDC must receive written comments on or before July 8, 2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0032 by either of the following methods:
[[Page 38149]]
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Human-Centered Design Effort on Bringing Guidelines to the Digital
Age--Existing Collection in Use Without an OMB Control Number--Office
of Public Health Data, Surveillance, and Technology (OPHDST), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
Given the increased demand to improve clinical guideline
development and implementation, a new approach that began with an
initiative on Adapting Clinical Guidelines for the Digital Age has been
expanded by Guidelines International Network (GIN) North America to
implement a future state of guideline development and implementation
that leverages advancements in technology. To identify pain points in
the process, CDC plans to engage individuals from multiple perspectives
in guideline development and implementation in discussion. CDC requests
approval for an Existing Collection in Use Without an OMB Control
Number for a data collection titled Human-Centered Design Effort on
Bringing Guidelines to the Digital Age.
CDC will use semi-structured interviews to collect data for this
study. The interviews will explore insights about guideline development
and implementation as well as pain points in this process. Data will be
used to inform the structure of a human-centered design workshop where
participants use the pain points identified as starting points for
designing solutions. Burden estimates include the time for respondents
to be participate in semi-structured interviews. CDC requests OMB
approval for an estimated 33 annual burden hours. There is no cost to
respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form Name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Clinicians.................... Clinician 5 1 1 5
Conversation
Guide.
EHR Vendors................... EHR Vendor 2 1 1 2
Conversation
Guide.
Guideline Developers.......... Guideline 8 1 1 8
Developer
Conversation
Guide.
Informaticists................ Informaticist 4 1 1 4
Conversation
Guide.
Implementers.................. Implementer 9 1 1 9
Conversation
Guide.
Insurers...................... Insurer 1 1 1 1
Conversation
Guide.
Patient/Patient Advocate...... Patient/Patient 4 1 1 4
Advocate
Conversation
Guide.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 33
----------------------------------------------------------------------------------------------------------------
[[Page 38150]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-09852 Filed 5-6-24; 8:45 am]
BILLING CODE 4163-18-P